Aurora Cannabis and ICC labs announced today the completion of the previously announced plan of arrangement pursuant to which Aurora has acquired all of the issued and outstanding common shares of ICC for $1.95 per share, reflecting an aggregate purchase price of approximately $290 million. ICC is now a wholly-owned subsidiary of Aurora. Completion of the Arrangement follows receipt of approval of the Arrangement from the Instituto de Regulación y Control del Cannabis, the Uruguayan regulatory authority overseeing the regulation and control of cannabis in Uruguay.

ICC’s common shares will be delisted from the TSX Venture Exchange, subject to TSX-V approval, and applications will be made for ICC to cease being a reporting issuer.

This transaction combines two pioneering cannabis companies with fully aligned international growth ambitions, immediately positioning Aurora as the market leader in Latin America, an area with well over 650 million people. Not only does ICC have substantial low cost, high-quality production capacity, it is the first company in Latin America which has completed a GMP compliant extraction facility, which will play an important role in supplying higher-margin CBD-based products for the global cannabis and wellness markets.

The acquisition of ICC establishes Aurora as the industry leader in Latin American, a region which encompasses more than 650 million people from across Mexico, the Caribbean, Central America, and South America. ICC, based in Uruguay, the first country in the world to legalize cannabis for adult consumer use, has developed a strong portfolio of high-quality, low-cost production assets, product offerings, and commercial agreements. Located in Uruguay’s free trade zone, ICC’s state-of-the-art science and GMP compliant processing facility, the first of its kind in Latin America, brings very significant capacity and early mover advantage to build significant market share both in Latin America and the international cannabis and wellness markets.

About Aurora 

Headquartered in Edmonton, Alberta, Canada with funded capacity in excess of 500,000 kg per annum and sales and operations in 20 countries across five continents, Aurora is one of the world’s largest and leading cannabis companies. Aurora is vertically integrated and horizontally diversified across every key segment of the value chain, from facility engineering and design to cannabis breeding and genetics research, cannabis and hemp production, derivatives, high value-add product development, home cultivation, wholesale and retail distribution.

FOLLOW CANNAIMPACT FOR MORE INDUSTRY HIGHLIGHTS

Highly differentiated from its peers, Aurora has established a uniquely advanced, consistent and efficient production strategy, based on purpose-built facilities that integrate leading-edge technologies across all processes, defined by extensive automation and customization, resulting in the massive scale production of high-quality product at low cost. Intended to be replicable and scalable globally, our production facilities are designed to produce cannabis of significant scale, with high quality, industry-leading yields, and low per gram production costs. Each of Aurora’s facilities is built to meet EU GMP standards, and its first production facility, the recently acquired MedReleaf Markham facility, and its wholly owned European medical cannabis distributor Aurora Deutschland, have achieved this level of certification.

Submit a Comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Top News

By Oren Todoros 17 Sep 19
Five Tips On How to Choose The Right C...

Before hiring a PR agency to help your cannabis company succeed, there are a few factors to determine which one is the best match to ...

By Oren Todoros 15 Sep 19
A New Era: Cannabis Goes Mainstream

Today cannabis or more specifically, CBD seems to be everywhere, from soaps to CBD gummies, cookies and many other common products. Here's how cannabis went ...

By Oren Todoros 29 Aug 19
2019 CannaImpact Cannabis Innovation A...

The CannaImpact Cannabis Innovation Awards are designed to honor cannabis companies and business trailblazers deserving recognition for industry innovation.